1. Home
  2. AMSS vs HBIO Comparison

AMSS vs HBIO Comparison

Compare AMSS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

HOLD

Current Price

$0.35

Market Cap

30.6M

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

SELL

Current Price

$8.24

Market Cap

26.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AMSS
HBIO
Founded
2016
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.6M
26.5M
IPO Year
2026
2000

Fundamental Metrics

Financial Performance
Metric
AMSS
HBIO
Price
$0.35
$8.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 140.7K
16.5K
Earning Date
08-14-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $116,176,000.00
Revenue This Year
$3.71
$3.76
Revenue Next Year
$20.00
$5.29
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.33
$0.38
52 Week High
$2.44
$8.80

Technical Indicators

Market Signals
Indicator
AMSS
HBIO
Relative Strength Index (RSI) 21.86 61.71
Support Level N/A $5.91
Resistance Level $0.81 N/A
Average True Range (ATR) 0.07 0.27
MACD -0.01 -0.01
Stochastic Oscillator 1.82 57.89

Price Performance

Historical Comparison
AMSS
HBIO

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: